Control of blood pressure levels in patients with premature coronary artery disease: Results from the Genetics of Atherosclerotic Disease study

High blood pressure (BP) is the major cardiovascular‐risk factor for coronary artery disease (CAD), principally in young patients who have an important and increasing socioeconomic burden. Despite the Seventh Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of clinical hypertension (Greenwich, Conn.) Conn.), 2020-07, Vol.22 (7), p.1253-1262
Hauptverfasser: Jorge‐Galarza, Esteban, Martínez‐Sánchez, Froylan D., Javier‐Montiel, Cesar I., Medina‐Urrutia, Aida X., Posadas‐Romero, Carlos, González‐Salazar, María C., Osorio‐Alonso, Horacio, Arellano‐Buendía, Abraham S., Juárez‐Rojas, Juan G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1262
container_issue 7
container_start_page 1253
container_title The journal of clinical hypertension (Greenwich, Conn.)
container_volume 22
creator Jorge‐Galarza, Esteban
Martínez‐Sánchez, Froylan D.
Javier‐Montiel, Cesar I.
Medina‐Urrutia, Aida X.
Posadas‐Romero, Carlos
González‐Salazar, María C.
Osorio‐Alonso, Horacio
Arellano‐Buendía, Abraham S.
Juárez‐Rojas, Juan G.
description High blood pressure (BP) is the major cardiovascular‐risk factor for coronary artery disease (CAD), principally in young patients who have an important and increasing socioeconomic burden. Despite the Seventh Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC‐7), recommended BP target
doi_str_mv 10.1111/jch.13942
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8029811</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2422008326</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4152-971b3d6e23fd864279a371d66641aba33544f389b9a5d5db62f5b26c483f27093</originalsourceid><addsrcrecordid>eNp1kc1u1DAUhS0EoqWw4AWQl3SRNv6Jk7BAqgZoQZWQEKwtx75hXDnxYDut5il4Ze6QUsECL2zr-vO5Pj6EvGT1GcNxfmO3Z0z0kj8ix6xtWNWyVj3GfcNlpbByRJ7lfFPXjRB9_ZQcCa6k5E17TH5u4lxSDDSOdAgxOrpLkPOSgAa4hZCpn-nOFA9zyfTOl-0BmEw5EDamOJu0pyYVwMX5DCbDG_oF8hKQH1OcaNkCvYQZirf50OYCCylmG3DGGn233qK5LG7_nDwZTcjw4n49Id8-vP-6uaquP19-3FxcV1aiq6pv2SCcAi5G1ynJ296IljmllGRmMEI0Uo6i64feNK5xg-JjM3BlZSdG3ta9OCFvV93dMkzgLNpLJuhd8hMa0tF4_e_J7Lf6e7zVXc37jjEUeH0vkOKPBXLRk88WQjAzxCVrLjmv6w5_GtHTFbVoOycYH9qwWh8C1Big_h0gsq_-ftcD-ScxBM5X4M4H2P9fSX_aXK2SvwDPp6iy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2422008326</pqid></control><display><type>article</type><title>Control of blood pressure levels in patients with premature coronary artery disease: Results from the Genetics of Atherosclerotic Disease study</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><creator>Jorge‐Galarza, Esteban ; Martínez‐Sánchez, Froylan D. ; Javier‐Montiel, Cesar I. ; Medina‐Urrutia, Aida X. ; Posadas‐Romero, Carlos ; González‐Salazar, María C. ; Osorio‐Alonso, Horacio ; Arellano‐Buendía, Abraham S. ; Juárez‐Rojas, Juan G.</creator><creatorcontrib>Jorge‐Galarza, Esteban ; Martínez‐Sánchez, Froylan D. ; Javier‐Montiel, Cesar I. ; Medina‐Urrutia, Aida X. ; Posadas‐Romero, Carlos ; González‐Salazar, María C. ; Osorio‐Alonso, Horacio ; Arellano‐Buendía, Abraham S. ; Juárez‐Rojas, Juan G.</creatorcontrib><description>High blood pressure (BP) is the major cardiovascular‐risk factor for coronary artery disease (CAD), principally in young patients who have an important and increasing socioeconomic burden. Despite the Seventh Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC‐7), recommended BP target &lt;140/90 mm Hg for patients with stable CAD, in 2017 the American College of Cardiology and the American Heart Association (ACC/AHA) updated BP target to &lt;130/80 mm Hg. We aimed to analyze the prevalence of BP control in patients with premature CAD using both criteria. In addition, antihypertensive therapy, lifestyle, clinical, and sociodemographic characteristics of the patients were evaluated in order to identify factors associated with the achievement of BP targets. The present study included 1206 patients with CAD diagnosed before 55 and 65 years old in men and women, respectively. Sociodemographic, clinical, and biochemical data were collected. The results indicate that 85.6% and 77.5% of subjects with premature CAD achieved JNC‐7 non‐strict and ACC/AHA strict BP target, respectively. Consistently, number of antihypertensive drugs and hypertension duration &gt;10 years were inversely associated with BP targets, whereas total physical activity and smoking were directly associated with BP targets, regardless of BP criteria. Considering that age, gender, and hypertension duration are non‐modifiable cardiovascular‐risk factors, our results highlight the need for more effective strategies focused on increase physical activity and smoking cessation in young patients with CAD. These healthier lifestyles changes should favor the BP target achievement and reduce the socioeconomic and clinical burden of premature CAD.</description><identifier>ISSN: 1524-6175</identifier><identifier>EISSN: 1751-7176</identifier><identifier>DOI: 10.1111/jch.13942</identifier><identifier>PMID: 32644257</identifier><language>eng</language><publisher>United States: John Wiley and Sons Inc</publisher><subject>Aged ; American Heart Association ; Antihypertensive Agents - pharmacology ; Antihypertensive Agents - therapeutic use ; antihypertensive drugs ; blood pressure ; Blood Pressure - drug effects ; cardiovascular‐risk factors ; Coronary Artery Disease - epidemiology ; Coronary Artery Disease - genetics ; Coronary Artery Disease - prevention &amp; control ; Coronary Heart Disease ; Female ; Humans ; hypertension ; Hypertension - drug therapy ; Hypertension - epidemiology ; Male ; Middle Aged ; Original Paper ; premature coronary artery disease ; United States</subject><ispartof>The journal of clinical hypertension (Greenwich, Conn.), 2020-07, Vol.22 (7), p.1253-1262</ispartof><rights>2020 Wiley Periodicals LLC</rights><rights>2020 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4152-971b3d6e23fd864279a371d66641aba33544f389b9a5d5db62f5b26c483f27093</citedby><cites>FETCH-LOGICAL-c4152-971b3d6e23fd864279a371d66641aba33544f389b9a5d5db62f5b26c483f27093</cites><orcidid>0000-0002-2719-1105 ; 0000-0001-5166-5027 ; 0000-0001-8864-2304</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029811/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029811/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,1417,1433,27924,27925,45574,45575,46409,46833,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32644257$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jorge‐Galarza, Esteban</creatorcontrib><creatorcontrib>Martínez‐Sánchez, Froylan D.</creatorcontrib><creatorcontrib>Javier‐Montiel, Cesar I.</creatorcontrib><creatorcontrib>Medina‐Urrutia, Aida X.</creatorcontrib><creatorcontrib>Posadas‐Romero, Carlos</creatorcontrib><creatorcontrib>González‐Salazar, María C.</creatorcontrib><creatorcontrib>Osorio‐Alonso, Horacio</creatorcontrib><creatorcontrib>Arellano‐Buendía, Abraham S.</creatorcontrib><creatorcontrib>Juárez‐Rojas, Juan G.</creatorcontrib><title>Control of blood pressure levels in patients with premature coronary artery disease: Results from the Genetics of Atherosclerotic Disease study</title><title>The journal of clinical hypertension (Greenwich, Conn.)</title><addtitle>J Clin Hypertens (Greenwich)</addtitle><description>High blood pressure (BP) is the major cardiovascular‐risk factor for coronary artery disease (CAD), principally in young patients who have an important and increasing socioeconomic burden. Despite the Seventh Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC‐7), recommended BP target &lt;140/90 mm Hg for patients with stable CAD, in 2017 the American College of Cardiology and the American Heart Association (ACC/AHA) updated BP target to &lt;130/80 mm Hg. We aimed to analyze the prevalence of BP control in patients with premature CAD using both criteria. In addition, antihypertensive therapy, lifestyle, clinical, and sociodemographic characteristics of the patients were evaluated in order to identify factors associated with the achievement of BP targets. The present study included 1206 patients with CAD diagnosed before 55 and 65 years old in men and women, respectively. Sociodemographic, clinical, and biochemical data were collected. The results indicate that 85.6% and 77.5% of subjects with premature CAD achieved JNC‐7 non‐strict and ACC/AHA strict BP target, respectively. Consistently, number of antihypertensive drugs and hypertension duration &gt;10 years were inversely associated with BP targets, whereas total physical activity and smoking were directly associated with BP targets, regardless of BP criteria. Considering that age, gender, and hypertension duration are non‐modifiable cardiovascular‐risk factors, our results highlight the need for more effective strategies focused on increase physical activity and smoking cessation in young patients with CAD. These healthier lifestyles changes should favor the BP target achievement and reduce the socioeconomic and clinical burden of premature CAD.</description><subject>Aged</subject><subject>American Heart Association</subject><subject>Antihypertensive Agents - pharmacology</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>antihypertensive drugs</subject><subject>blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>cardiovascular‐risk factors</subject><subject>Coronary Artery Disease - epidemiology</subject><subject>Coronary Artery Disease - genetics</subject><subject>Coronary Artery Disease - prevention &amp; control</subject><subject>Coronary Heart Disease</subject><subject>Female</subject><subject>Humans</subject><subject>hypertension</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original Paper</subject><subject>premature coronary artery disease</subject><subject>United States</subject><issn>1524-6175</issn><issn>1751-7176</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1u1DAUhS0EoqWw4AWQl3SRNv6Jk7BAqgZoQZWQEKwtx75hXDnxYDut5il4Ze6QUsECL2zr-vO5Pj6EvGT1GcNxfmO3Z0z0kj8ix6xtWNWyVj3GfcNlpbByRJ7lfFPXjRB9_ZQcCa6k5E17TH5u4lxSDDSOdAgxOrpLkPOSgAa4hZCpn-nOFA9zyfTOl-0BmEw5EDamOJu0pyYVwMX5DCbDG_oF8hKQH1OcaNkCvYQZirf50OYCCylmG3DGGn233qK5LG7_nDwZTcjw4n49Id8-vP-6uaquP19-3FxcV1aiq6pv2SCcAi5G1ynJ296IljmllGRmMEI0Uo6i64feNK5xg-JjM3BlZSdG3ta9OCFvV93dMkzgLNpLJuhd8hMa0tF4_e_J7Lf6e7zVXc37jjEUeH0vkOKPBXLRk88WQjAzxCVrLjmv6w5_GtHTFbVoOycYH9qwWh8C1Big_h0gsq_-ftcD-ScxBM5X4M4H2P9fSX_aXK2SvwDPp6iy</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Jorge‐Galarza, Esteban</creator><creator>Martínez‐Sánchez, Froylan D.</creator><creator>Javier‐Montiel, Cesar I.</creator><creator>Medina‐Urrutia, Aida X.</creator><creator>Posadas‐Romero, Carlos</creator><creator>González‐Salazar, María C.</creator><creator>Osorio‐Alonso, Horacio</creator><creator>Arellano‐Buendía, Abraham S.</creator><creator>Juárez‐Rojas, Juan G.</creator><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2719-1105</orcidid><orcidid>https://orcid.org/0000-0001-5166-5027</orcidid><orcidid>https://orcid.org/0000-0001-8864-2304</orcidid></search><sort><creationdate>202007</creationdate><title>Control of blood pressure levels in patients with premature coronary artery disease: Results from the Genetics of Atherosclerotic Disease study</title><author>Jorge‐Galarza, Esteban ; Martínez‐Sánchez, Froylan D. ; Javier‐Montiel, Cesar I. ; Medina‐Urrutia, Aida X. ; Posadas‐Romero, Carlos ; González‐Salazar, María C. ; Osorio‐Alonso, Horacio ; Arellano‐Buendía, Abraham S. ; Juárez‐Rojas, Juan G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4152-971b3d6e23fd864279a371d66641aba33544f389b9a5d5db62f5b26c483f27093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>American Heart Association</topic><topic>Antihypertensive Agents - pharmacology</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>antihypertensive drugs</topic><topic>blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>cardiovascular‐risk factors</topic><topic>Coronary Artery Disease - epidemiology</topic><topic>Coronary Artery Disease - genetics</topic><topic>Coronary Artery Disease - prevention &amp; control</topic><topic>Coronary Heart Disease</topic><topic>Female</topic><topic>Humans</topic><topic>hypertension</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original Paper</topic><topic>premature coronary artery disease</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jorge‐Galarza, Esteban</creatorcontrib><creatorcontrib>Martínez‐Sánchez, Froylan D.</creatorcontrib><creatorcontrib>Javier‐Montiel, Cesar I.</creatorcontrib><creatorcontrib>Medina‐Urrutia, Aida X.</creatorcontrib><creatorcontrib>Posadas‐Romero, Carlos</creatorcontrib><creatorcontrib>González‐Salazar, María C.</creatorcontrib><creatorcontrib>Osorio‐Alonso, Horacio</creatorcontrib><creatorcontrib>Arellano‐Buendía, Abraham S.</creatorcontrib><creatorcontrib>Juárez‐Rojas, Juan G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The journal of clinical hypertension (Greenwich, Conn.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jorge‐Galarza, Esteban</au><au>Martínez‐Sánchez, Froylan D.</au><au>Javier‐Montiel, Cesar I.</au><au>Medina‐Urrutia, Aida X.</au><au>Posadas‐Romero, Carlos</au><au>González‐Salazar, María C.</au><au>Osorio‐Alonso, Horacio</au><au>Arellano‐Buendía, Abraham S.</au><au>Juárez‐Rojas, Juan G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Control of blood pressure levels in patients with premature coronary artery disease: Results from the Genetics of Atherosclerotic Disease study</atitle><jtitle>The journal of clinical hypertension (Greenwich, Conn.)</jtitle><addtitle>J Clin Hypertens (Greenwich)</addtitle><date>2020-07</date><risdate>2020</risdate><volume>22</volume><issue>7</issue><spage>1253</spage><epage>1262</epage><pages>1253-1262</pages><issn>1524-6175</issn><eissn>1751-7176</eissn><abstract>High blood pressure (BP) is the major cardiovascular‐risk factor for coronary artery disease (CAD), principally in young patients who have an important and increasing socioeconomic burden. Despite the Seventh Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC‐7), recommended BP target &lt;140/90 mm Hg for patients with stable CAD, in 2017 the American College of Cardiology and the American Heart Association (ACC/AHA) updated BP target to &lt;130/80 mm Hg. We aimed to analyze the prevalence of BP control in patients with premature CAD using both criteria. In addition, antihypertensive therapy, lifestyle, clinical, and sociodemographic characteristics of the patients were evaluated in order to identify factors associated with the achievement of BP targets. The present study included 1206 patients with CAD diagnosed before 55 and 65 years old in men and women, respectively. Sociodemographic, clinical, and biochemical data were collected. The results indicate that 85.6% and 77.5% of subjects with premature CAD achieved JNC‐7 non‐strict and ACC/AHA strict BP target, respectively. Consistently, number of antihypertensive drugs and hypertension duration &gt;10 years were inversely associated with BP targets, whereas total physical activity and smoking were directly associated with BP targets, regardless of BP criteria. Considering that age, gender, and hypertension duration are non‐modifiable cardiovascular‐risk factors, our results highlight the need for more effective strategies focused on increase physical activity and smoking cessation in young patients with CAD. These healthier lifestyles changes should favor the BP target achievement and reduce the socioeconomic and clinical burden of premature CAD.</abstract><cop>United States</cop><pub>John Wiley and Sons Inc</pub><pmid>32644257</pmid><doi>10.1111/jch.13942</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-2719-1105</orcidid><orcidid>https://orcid.org/0000-0001-5166-5027</orcidid><orcidid>https://orcid.org/0000-0001-8864-2304</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1524-6175
ispartof The journal of clinical hypertension (Greenwich, Conn.), 2020-07, Vol.22 (7), p.1253-1262
issn 1524-6175
1751-7176
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8029811
source MEDLINE; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); PubMed Central
subjects Aged
American Heart Association
Antihypertensive Agents - pharmacology
Antihypertensive Agents - therapeutic use
antihypertensive drugs
blood pressure
Blood Pressure - drug effects
cardiovascular‐risk factors
Coronary Artery Disease - epidemiology
Coronary Artery Disease - genetics
Coronary Artery Disease - prevention & control
Coronary Heart Disease
Female
Humans
hypertension
Hypertension - drug therapy
Hypertension - epidemiology
Male
Middle Aged
Original Paper
premature coronary artery disease
United States
title Control of blood pressure levels in patients with premature coronary artery disease: Results from the Genetics of Atherosclerotic Disease study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T10%3A44%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Control%20of%20blood%20pressure%20levels%20in%20patients%20with%20premature%20coronary%20artery%20disease:%20Results%20from%20the%20Genetics%20of%20Atherosclerotic%20Disease%20study&rft.jtitle=The%20journal%20of%20clinical%20hypertension%20(Greenwich,%20Conn.)&rft.au=Jorge%E2%80%90Galarza,%20Esteban&rft.date=2020-07&rft.volume=22&rft.issue=7&rft.spage=1253&rft.epage=1262&rft.pages=1253-1262&rft.issn=1524-6175&rft.eissn=1751-7176&rft_id=info:doi/10.1111/jch.13942&rft_dat=%3Cproquest_pubme%3E2422008326%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2422008326&rft_id=info:pmid/32644257&rfr_iscdi=true